{ "@context": "https://frontierpicks.com/schemas/dossier.v1.json", "ticker": "ALM", "name": "Almonty Industries Inc.", "url": "https://frontierpicks.com/dossiers/ALM/", "json_url": "https://frontierpicks.com/dossiers/ALM.json", "status": "DORMANT", "current_conviction": "MEDIUM", "graded_conviction": "MEDIUM", "archetype": { "code": "a1", "n": 1 }, "current_thesis": "Non-China tungsten narrative now trades on one venue: the TSX exit took effect 2026-07-31 and the ASX removal 2026-09-01, leaving Nasdaq and Frankfurt. The operating case is unchanged — Sangdong throughput since 2026-07-01, Q2 revenue C$43.0M (+498%) on APT at US$3,075/MTU — but August APT slipped to US$2,900–3,000/mtu and the shares sit 25.0% under $23.42, a maturing narrative with no company-dated catalyst before the ~2026-11-12 print.", "invalidation_trigger": "A weekly close below $15.50 erases the post-buyback advance and returns the shares into the pre-Q2-print range; secondarily, monthly European APT averaging under US$2,000/MTU, or a Q3 print (~2026-11-12, est.) with a second consecutive revenue miss and adjusted EBITDA not expanding from C$17.6M.", "catalyst_date": null, "outcome": "INVALIDATED", "outcome_date": "2026-09-18", "invalidation_fired": true, "themes": [ "critical-materials-rare-earths", "defense-aerospace" ], "tags": [], "sources": [], "notes": [ "Reports in Canadian dollars; US wires convert, so C$43.0M Q2 revenue printed as ~US$31.1M against USD consensus — check the currency before comparing to estimates.", "Listing consolidated: TSX exit effective 2026-07-31, ASX removal 2026-09-01. Shares now trade only on Nasdaq (ALM) and Frankfurt (ALI1); the TSX line AII no longer exists.", "Embedded-derivative and capped-call liabilities from the convertible structure make GAAP net income swing on non-cash revaluation (C$173.1M net gain in Q2 FY26).", "The US$300M / 14.4M-share program approved 2026-08-17 runs to 2029-08-24 as an authorization, not a commitment; actual repurchases are disclosed after the fact.", "Files as a foreign private issuer on Form 6-K rather than 10-Q, so interim disclosure is release-driven and quarterly detail arrives on the company's own schedule." ], "body_markdown": "## Current Thesis\n\nAlmonty Industries' non-China tungsten production thesis has failed its published price test; Sangdong's next quarterly results must establish whether the operating case survives. The 2026-09-18 weekly close of $13.84 breached the $15.50 invalidation published on 2026-09-06. That is an observed failure of the prior price structure, not evidence that the mine has stopped operating.\n\nThe substantive development since the previous note is the 2026-09-14 binding Rwanda partnership. Almonty announced a 75% interest in the venture, with Rwanda receiving 25% for an exploration concession and processing licence. The agreement contemplates sourcing material from existing licensed producers; it does not establish realized revenue from that activity. [Company announcement](https://www.nasdaq.com/press-release/almonty-and-government-rwanda-form-strategic-tungsten-partnership-2026-09-14)\n\nFor the previously published price-supported advance, the narrative is dead — the 2026-09-18 close broke its stated threshold despite the Rwanda announcement. This is an inference about that narrative leg. A weekly recovery above $15.50 accompanied by stronger reported operating earnings would challenge the assessment.\n\n## Bull Case\n\n- **Operating earnings provide a benchmark.** The 2026-08-11 second-quarter release reported revenue of C$43.0 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of C$17.6 million. These establish the operating comparison for the next results. [Company results](https://www.nasdaq.com/press-release/almonty-industries-reports-second-quarter-2026-financial-results-2026-08-11)\n- **Contract terms support the production case.** The same release disclosed that the 2026-07-14 Global Tungsten & Powders amendment extended the agreement by six years, increased contracted volumes by 40% and improved pricing by approximately 6.3%. Those are contractual changes; realized revenue still depends on deliveries. [Company results](https://www.nasdaq.com/press-release/almonty-industries-reports-second-quarter-2026-financial-results-2026-08-11)\n- **Rwanda broadens the sourcing route.** The 2026-09-14 agreement provides for acquiring ore, pre-concentrate and tailings from licensed producers, with exports contemplated before construction of a permanent processing plant. Actual shipment and revenue disclosures would establish whether this additional route contributes commercially. [Company announcement](https://www.nasdaq.com/press-release/almonty-and-government-rwanda-form-strategic-tungsten-partnership-2026-09-14)\n\n## Bear Case\n\n- **The published threshold has failed.** The adjusted market close was $13.84 on 2026-09-18, below the $15.50 weekly threshold in the 2026-09-06 research note. Retaining that threshold records the failure without substituting an unsupported lower level.\n- **Revenue already missed expectations.** Benzinga's 2026-08-11 earnings report recorded second-quarter sales of US$31.053 million against US$35.038 million expected. A further miss accompanied by adjusted EBITDA no higher than the reported second-quarter C$17.6 million would undermine the operating expansion case.\n- **Commodity pricing had softened.** The China Tungsten Industry Association's 2026-08-31 review placed European ammonium paratungstate (APT) at US$2,900–3,000 per metric tonne unit, below the company's second-quarter average of US$3,075 per metric tonne unit. September's comparable average is missing, so continued deterioration cannot be asserted.\n\n## Setup & Price Structure\n\nThe supplied adjusted daily series records a 2026-09-18 close of $13.84, a three-month decline of 25.8%, and a price 40.9% below the trailing 52-week high of $23.42. The 14-period relative strength index was 26.7 on that date. These measurements describe weakness; they do not establish a reversal or a new support shelf.\n\nAnalyst support persisted during the decline: D.A. Davidson maintained its US$33 price target on 2026-09-15, according to Benzinga's analyst-action record. That is an observable research opinion, not evidence of purchases or expanding participation. [Benzinga analyst record](https://www.benzinga.com/quote/alm/price-targets)\n\nNo dated moving-average series, short-interest figure or fund-flow series is available in the evidence reviewed. Analyst coverage and the 2026-09-18 price decline therefore cannot establish how crowded ownership is.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-09-30 — Third-quarter accounting cutoff.** The quarter closes after Sangdong's company-announced 2026-07-01 start of processing operations. This is an accounting milestone, not a scheduled results release; it defines the period for assessing the production contribution. [Company processing announcement](https://almonty.com/almonty-commences-processing-operations-at-sangdong-mine/)\n- **~2026-11-12, est. Third-quarter results.** This remains the unconfirmed estimate carried in the 2026-09-06 public note, outside the next 30 days. The relevant comparisons are revenue against contemporaneous expectations and adjusted EBITDA against the C$17.6 million reported on 2026-08-11. No company-confirmed release date was identified.\n\nNo company-confirmed earnings, shipment or commissioning announcement date was identified for the next 30 days as of 2026-09-20.\n\n## What Would Change Our Mind\n\nThe lost post-authorization price structure is the decisive change: a weekly close below $15.50 was the published thesis-break condition, and the 2026-09-18 close of $13.84 satisfied it. The earlier case is invalidated.\n\nA renewed production-led case would require both a weekly close above the former $15.50 threshold and quarterly evidence of stronger operations: revenue meeting contemporaneous consensus and adjusted EBITDA exceeding the second-quarter C$17.6 million reported on 2026-08-11. A subsequent weekly close below $15.50 would invalidate that recovery interpretation; another revenue miss with no EBITDA expansion would reject its operating premise.\n\n## Correlation Notes\n\nThis remains a single-name assessment. The 2026-08-11 results and the 2026-08-31 European APT quotation identify tungsten pricing as an operating exposure, but the available observations are too few to support a measured equity-price correlation.\n\nBenzinga's 2026-09-10 market report described falling Nasdaq prices alongside higher oil prices and Treasury yields. Without matched daily returns for Almonty and those markets, that episode cannot establish whether macro conditions explain the company's decline.", "first_seen": "2026-08-28", "last_analyzed": "2026-09-19T23:07:37+00:00", "last_synthesized": "2026-09-19", "last_update_source": "watchlist_research", "license": "Content © FrontierPicks. Cite the canonical URL." }